Transplacental arsenic carcinogenesis in mice

Toxicology and Applied Pharmacology

Volumn 222, Issue 3, 2007, Pages 271-280

  Waalkes, Michael P ^a   Liu, Jie ^a   Diwan, Bhalchandra A ^b  

^a National Cancer Institute   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Adrenal; Arsenic; Bladder; Carcinogenesis; Liver; Ovary

Indexed keywords

ARSENIC ACID; ARSENITE SODIUM; DIETHYLSTILBESTROL; DRINKING WATER; PHORBOL 13 ACETATE 12 MYRISTATE; TAMOXIFEN;

ADRENAL CORTEX ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; BLADDER PAPILLOMA; CELL PROLIFERATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GESTATION PERIOD; HYPERPLASIA; KIDNEY DISEASE; LIVER CARCINOMA; LIVER TUMOR; LUNG CARCINOMA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OVARY TUMOR; PERINATAL PERIOD; PRENATAL EXPOSURE; PROGENY; TRANSPLACENTAL CARCINOGENESIS; UROGENITAL TRACT TUMOR; UTERINE TUBE TUMOR; UTERUS TUMOR; WATER CONTENT;

ANIMALS; ANTICARCINOGENIC AGENTS; ARSENIC; ARSENICALS; CARCINOGENS; CARCINOMA, TRANSITIONAL CELL; DATA INTERPRETATION, STATISTICAL; DIETHYLSTILBESTROL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED C3H; NEOPLASMS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TAMOXIFEN; TETRADECANOYLPHORBOL ACETATE; URINARY BLADDER NEOPLASMS;

MUS;

EID: 34547611245     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.12.034     Document Type: Article

References (61)

1. Anderson L.M. Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determination. Toxicol. Appl. Pharmacol. 199 (2004) 162-174
2. Anderson L.M., Diwan B.A., Fear N.T., and Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ. Health Perspect. 108 (2000) 573-594
3. Aposhian H.V., Zakharyan R.A., Avram M.D., Sampayo-Reyes A., and Wollenberg M.L. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol. Appl. Pharmacol. 198 (2004) 327-335
4. Birnbaum L.S., and Fenton S.E. Cancer and developmental exposure to endocrine disruptors. Environ. Health Perspect. 111 (2003) 389-394
5. Burns F.J., Uddin A.N., Wu F., Nadas A., and Rossman T.G. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ. Health Perspect. 112 (2004) 599-603
6. Carter D.E., Aposhian H.V., and Gandolfi A.J. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol. Appl. Pharmacol. 193 (2003) 309-334
7. Chen H., Li S., Liu J., Diwan B.A., Barrett J.C., and Waalkes M.P. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 25 (2004) 1779-1786
8. Cohen S.M., Yamamoto S., Cano M., and Arnold L.L. Uroepithelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats. Toxicol. Sci. 59 (2001) 68-74
9. Cohen S.M., Arnold L.L., Uzvolgyi E., Cano M., St. John M., Yamamoto S., Lu X., and Le X.C. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15 (2002) 1150-1157
10. Concha G., Vogler G., Lezcano D., Nermell B., and Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci. 44 (1998) 185-190
11. Cook J.D., Davis B.J., Cai S.L., Barrett J.C., Conti C.J., and Walker C.L. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8644-8649
12. Couse J.F., Davis V.L., Hanson R.B., Jefferson W.N., McLachlan J.A., Bullock B.C., Newbold R.R., and Korach K.S. Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol. Mol. Carcinog. 19 (1997) 236-242
13. Deane N.G., Parker M.A., Aramandla R., Diehl L., Lee W.J., Washington M.K., Nanney L.B., Shyr Y., and Beauchamp R.D. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res. 61 (2001) 5389-5395
14. Devesa V., Adair B.M., Liu J., Waalkes M.P., Diwan B.A., Styblo M., and Thomas D.V. Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology 224 (2006) 147-155
15. Dickson R.B., and Stancel G.M. Estrogen receptor-mediated processes in normal and cancer cells. J. Natl. Cancer Inst. Monographs 27 (2000) 135-145
16. Diwan B.A., Anderson L.M., Rehm S., and Rice J.M. Transplacental carcinogenicity of cisplatin: Initiation of skin tumors and induction of other preneoplastic and neoplastic lesions in SENCAR mice. Cancer Res. 53 (1993) 3874-3876
17. Diwan B.A., Anderson L.M., and Ward J.M. Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen. Carcinogenesis 18 (1997) 2009-2014
18. Germolec D.R., Spalding J., Boorman G.A., Wilmer J.L., Yoshida T., Simeonova P.P., Bruccoleri A., Kayama F., Gaido K., Tennant R., Burleson F., Dong W., Lang R.W., and Luster M.I. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat. Res. 386 (1997) 209-218
19. Germolec D.R., Spalding J., Yu H.S., Chen G.S., Simeonova P.P., Humble M.C., Bruccoleri A., Boorman G.A., Foley J.F., Yoshida T., and Luster M.I. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol. 153 (1998) 1775-1785
20. Goerttler K., and Lohrke H. Diaplacental carcinogenesis: tumor localization and tumor incidence in NMRI mice after diaplacental initiation with DMBA and urethane and postnatal promotion and the phorbol ester TPA in a modified 2-stage Berenblum/Mottram experiment. Virchows Arch. 376 (1977) 117-132
21. Goerttler K., Loehrke H., Hesse B., Milz A., and Schweizer J. Diaplacental initiation of NMRI mice with 7,12-dimethylbenz[a]anthracene during gestation days 6-20 and postnatal treatment of the F1-generation with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate: tumor incidence in organs other than the skin. Carcinogenesis 2 (1981) 1087-1094
22. He X.Y., Smith G.J., Enno A., and Nicholson R.C. Short-term diethylnitrosamine-induced oval cell responses in three strains of mice. Pathology 26 (1994) 154-160
23. Hood R.D., Vedel-Macrander G.C., Zaworotko M.J., Tatum F.M., and Meeks R.G. Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology 35 (1987) 19-25
24. Humble M.C., Trempus C.S., Spalding J.W., Cannon R.E., and Tennant R.W. Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review. Oncogene 24 (2005) 8217-8228
25. IARC. Arsenic in drinking water. International agency for research on cancer monographs on the evaluation of carcinogenic risk to humans. Some Drinking Water Disinfectants and Contaminants, Including Arsenic vol. 84 (2004), IARC Press, Lyon 269-477
26. Lee G.H., and Drinkwater N.R. The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ mice. Carcinogenesis 16 (1995) 1993-1996
27. Liu J., Xie Y., Ward J.M., Diwan B.A., and Waalkes M.P. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol. Sci. 77 (2004) 249-257
28. Liu J., Xie Y., Ducharme D., Shen J., Diwan B.A., Merrick A.B., Grissom S., Tucker J.C., Paules R., Tennant R., and Waalkes M.P. Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ. Health Perspect. 114 (2006) 404-411
29. Liu J., Xie Y., Merrick A.B., Shen J., Ducharme D., Collins J., Diwan B.A., Logsdon D., and Waalkes M.P. Transplacental arsenic plus postnatal 12-O-teradecanoyl-13-acetate exposures associated with hepatocarcinogenesis induce similar gene expression patterns in male and female mouse liver. Toxicol. Appl. Pharmacol. 213 (2006) 216-223
30. Lu M., Wang H., Li X.F., Lu X., Cullen W.R., Arnold L.L., Cohen S.M., and Le X.C. Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem. Res. Toxicol. 17 (2004) 1733-1742
31. Maita K., Hirano M., Harada T., Mitsumori K., Hoshida A., Takahashi K., Nakashima N., Kitazawa T., Enomoto A., Inui K., and Shirasu Y. Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol. Pathol. 16 (1998) 340-349
32. Miyazaki Y., Tsuchida S., Nishimura H., Pope J.C., Harris R.C., McKanna J.M., Inagami T., Hogan B.L.M., Fogo A., and Ichikawa I. Angiotensin induces the urinary peristaltic machinery during the perinatal period. J. Clin. Invest. 102 (1998) 1489-1497
33. Moritz K.M., and Wintour E.M. Functional development of the meso- and metanephrous. Pediatr. Nephrol. 13 (1999) 171-178
34. Motiwale L., Ingle A.D., and Rao K.V.K. Mouse skin tumor promotion by sodium arsenate is associated with enhanced PCNA expression. Cancer Lett. 223 (2005) 27-35
35. Newbold R.R. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol. Appl. Pharmacol. 199 (2004) 142-150
36. Newbold R.R., Jefferson W.N., Padilla-Burgos E., and Bullock B. Uterine carcinoma in mice treated neonatally with tamoxifen. Carcinogenesis 18 (1997) 2293-2298
37. Noble R.L., Hochachka B.C., and King D. Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. Cancer Res. 35 (1975) 766-780
38. NTP. Arsenic compounds, inorganic. National Toxicology Program Report on Carcinogens. 11th edition (2004), U.S. Department of Health and Human Services, Research Triangle Park, NC III18-III20
39. NTP. Estrogens, steroidal. National Toxicology Program Report on Carcinogens. 11th edition (2004), U.S. Department of Health and Human Services, Research Triangle Park, NC III115-III117
40. NTP. Diethylstilbestrol. National Toxicology Program Report on Carcinogens. 11th edition (2004), U.S. Department of Health and Human Services, Research Triangle Park, NC III98-III99
41. NTP. Tamoxifen. National Toxicology Program, Report on Carcinogens. 11th edition (2004), U.S. Department of Health and Human Services, Research Triangle Park, NC III239-III241
42. NTP. Introduction. National Toxicology Program Report on Carcinogens. 11th edition (2004), U.S. Department of Health and Human Services, Research Triangle Park, NC I1-I6
43. NRC. Arsenic in the Drinking Water (1999), National Research Council. National Academy, Washington, DC
44. NRC. Arsenic in the Drinking Water; 2001 Update (2001), National Research Council. National Academy, Washington, DC
45. Pi J., Yamauchi H., Kumagai Y., Sun G., Yoshida T., Aikawa H., Hopenhayn-Rich C., and Shimojo N. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ. Health Perspect. 110 (2002) 331-336
46. Rossman T.G., Uddin A.N., Burns F.J., and Bosland M.C. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol. 176 (2001) 64-71
47. Smith A.H., Marshall G., Yuan Y., Ferreccio C., Liaw J., von Ehrenstein O., Steinmaus C., Bates M.N., and Selvin S. Increased mortality from cancer and brochiectasis in young adults after exposure to arsenic in utero and early in early childhood. Environ. Health Perspect. 114 (2006) 1293-1296
48. Styblo M., Drobna Z., Jaspers I., Lin S., and Thomas D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update. Environ. Health Perspect. 110 (2002) 767-771
49. Sun J.M., Spencer V.A., Li L., Yu Chen H., Yu J., and Davie J.R. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins. Exp. Cell Res. 302 (2005) 96-107
50. Uddin A.N., Burns F.J., and Rossman T.G. Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin. Carcinogenesis 26 (2005) 2179-2186
51. Waalkes M.P., Keefer L.K., and Diwan B.A. Induction of proliferative lesions of the uterus, testes, and liver in Swiss mice given repeated injections of sodium arsenate; Possible estrogenic mode of action. Toxicol. Appl. Pharmacol. 166 (2000) 24-35
52. Waalkes M.P., Ward J.M., Liu J., and Diwan B.A. Transplacental carcinogenicity of inorganic arsenic in the drinking water: Induction of hepatic, ovarian, pulmonary and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 86 (2003) 7-17
53. Waalkes M.P., Ward J.M., and Diwan B.A. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: Promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25 (2004) 133-141
54. Waalkes M.P., Liu J., Chen H., Xie Y., Achanzar W.E., Zhou Y.S., Cheng M.L., and Diwan B.A. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst. 96 (2004) 466-474
55. Waalkes M.P., Liu J., Ward J.M., Powell D.A., and Diwan B.A. Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res. 66 (2006) 1337-1345
56. Waalkes M.P., Liu J., Ward J.M., and Diwan B.A. Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol. Appl. Pharmacol. 215 (2006) 295-303
57. Wei M., Wanibuchi H., Yamamoto S., Li W., and Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 20 (1999) 1873-1876
58. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., Nakae D., and Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23 (2002) 1387-1397
59. Wei M., Arnold L., Cano M., and Cohen S.M. Effects of co-administration of antioxidants and arsenicals on the rat urinary bladder epithelium. Toxicol. Sci. 83 (2005) 237-245
60. Williams G.M., Iatropoulos M., Cheung R., Radi L., and Wang C.X. Diethylstilbestrol liver carcinogenicity and modification of DNA in rats. Cancer Lett. 68 (1993) 193-198
61. Yager J.D., and Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 203-232